# US 2001/0034486 A1 · In vivo biocompatible acoustic coupling media

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0034486 A1
- Document ID: US20010034486A1
- Status: Published application
- Kind: A1
- Application number: 09/804,124
- Filed: 2001-03-12
- Published: 2001-10-25
- Earliest claimed: 1998-10-09
- Assignees: Sonotech, Inc.
- Inventors: Margaret J. Larson; John W. Rutter; Larry L. Smith
- Web page: https://patentgrep.com/patent/US20010034486A1

## CPC

- A61L 31/18: Materials at least partially X-ray or laser opaque
- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- C08L 71/02: Polyalkylene oxides
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

A medical ultrasound coupling media and lubricant, in gel or liquid form, comprised of polyethylene oxide (PEO), and aqueous solvent solutions. The inventive coupling media provides long term biocompatibility (bio-inert, bioerodable or biodegraded and excreted) in vivo with human tissue and body fluids. The ultrasound coupling and lubricating media is formulated and manufactured in such manner and form that renders the acoustic media sterile, non-cross-linked, pseudoplastic, and containing acceptably low levels of pyrogens.

## Claims

### Claim 1

An ultrasound couplant and medical device lubricant comprising polyethylene oxide in a concentration amount of about 0.05 wt. % to about 65 wt. %, the balance water.

### Claim 2 (depends on 1)

The ultrasound couplant and medical device lubricant of claim 1 wherein said polyethylene oxide has a molecular weight of about 100,000 to about 8,000,000.

### Claim 3 (depends on 1)

The ultrasound couplant and medical device lubricant of claim 1 wherein said polyethylene oxide has a molecular weight of about 200,000 to about 2,000,000.

### Claim 4 (depends on 1)

The ultrasound couplant and medical device lubricant of claim 1 wherein said polyethylene oxide has a molecular weight of about 600,000.

### Claim 5 (depends on 4)

The ultrasound couplant and medical device lubricant of claim 4 comprising polyethylene oxide in a concentration amount of about 0.05 wt. % to about 10 wt %.

### Claim 6 (depends on 4)

The ultrasound couplant and medical device lubricant of claim 4 comprising polyethylene oxide in a concentration amount of about 4 wt. %.

### Claim 7 (depends on 6)

The ultrasound couplant and medical device lubricant of claim 6 further comprising propylene glycol in an amount of 18 wt. %.

### Claim 8 (depends on 1)

The ultrasound couplant and medical device lubricant of claim 1 wherein said ultrasound couplant is biocompatible with body fluids and tissue.

### Claim 9 (depends on 1)

The ultrasound couplant and medical device lubricant of claim 1 being an in vivo biocompatible ultrasound couplant and medical device lubricant.

### Claim 10 (depends on 9)

The ultrasound couplant and medical device lubricant of claim 9 being biodegradable, bio-inert, or bio-erodable within a body.

### Claim 11 (depends on 1)

The ultrasound couplant and medical device lubricant of claim 1 being sterilizable by heat.

### Claim 12 (depends on 9)

The ultrasound couplant and medical device lubricant of claim 9 wherein said couplant is biodegradable within a body.

### Claim 13 (depends on 1)

The ultrasound couplant and medical device lubricant of claim 1 having a viscosity of about 4,000 centipoise.

### Claim 14 (depends on 1)

The ultrasound couplant and medical device lubricant of claim 1 wherein said water is sterile having low and acceptable levels of pyrogens.

### Claim 15 (depends on 1)

The ultrasound couplant and medical device lubricant of claim 1 being in the form of a fluid or gel.

### Claim 16 (depends on 1)

The ultrasound couplant and medical device lubricant of claim 1 being excretable from within the human body through natural pathways and processes.

### Claim 17 (depends on 1)

The ultrasound couplant and medical device lubricant of claim 1 further comprising polyalkylene glycol in the amount of 1 to 45 wt. %.

### Claim 18

An ultrasound couplant and medical device lubricant comprising polyethylene oxide in a concentration amount of about 0.05 wt. % to about 65 wt. %, polyalkylene glycol in the amount of 1 to 45 wt. %, and the balance water.

### Claim 19 (depends on 18)

The ultrasound couplant and medical device lubricant of claim 18 wherein said polyalkylene glycol comprises propylene glycol.

### Claim 20

An in vivo biocompatible ultrasound couplant and medical device lubricant comprising polyethylene oxide in a concentration amount of about 0.05 wt. % to about 65 wt. %, the balance water.

### Claim 21 (depends on 20)

The in vivo biocompatible ultrasound couplant and medical device lubricant of claim 20 wherein said polyethylene oxide has a molecular weight of about 100,000 to about 2,000,000.

### Claim 22 (depends on 21)

The in vivo biocompatible ultrasound couplant and medical device lubricant of claim 21 comprising polyethylene oxide in a concentration amount of about 0.05 wt. % to about 35 wt. %.

### Claim 23 (depends on 22)

The in vivo biocompatible ultrasound couplant and medical device lubricant of claim 22 wherein said polyethylene oxide has a molecular weight of about 200,000 to about 2,000,000.

### Claim 24 (depends on 23)

The in vivo biocompatible ultrasound couplant and medical device lubricant of claim 23 comprising polyethylene oxide in a concentration amount of about 1% to about 20%.

### Claim 25

An in vivo biocompatible ultrasound couplant and medical device lubricant comprising polyethylene oxide in a concentration amount of about 0.05 wt. % to about 65 wt. %, polyalkylene glycol in the amount of 1 to 45 wt. %, and the balance water.

### Claim 26 (depends on 25)

The in vivo biocompatible ultrasound couplant and medical device lubricant of claim 25 wherein said polyalkylene glycol comprises propylene glycol.

### Claim 27

A method of conducting ultrasound energy between an ultrasound transducer and a target to be imaged from within a body cavity, said method comprising:
providing said transducer with an active area for transmitting and receiving said ultrasound energy,
applying an ultrasound couplant to at least one of said target, said transducer, within a transducer cover fitted onto said transducer, and on the exterior of a transducer cover fitted onto said transducer, said couplant being in vivo biocompatible and comprising polyethylene oxide in a concentration amount of about 0.05 wt. % to about 65 wt. %, the balance water, said couplant having acoustic properties generally equivalent to acoustic properties of said target,
placing said transducer into said body cavity aided by the lubricity of said couplant with said active area in contact with said couplant on said target,
transmitting and receiving said ultrasound energy respectively to and/or from said target through said ultrasound couplant,
whereby subsequent to said transmitting and receiving, said transducer is removed from said cavity and said couplant remains within the body cavity by design or by accident, where it is biodegradable, bio-inert or bioerodable with respect to said target and said body cavity.

### Claim 28 (depends on 27)

The method of claim 27 wherein said ultrasound couplant further comprises polyalkylene glycol in the amount of 1 to 45 wt. %.

### Claim 29 (depends on 28)

The method of claim 28 wherein said polyalkylene glycol comprises propylene glycol.

### Claim 30

A method of conducting ultrasound energy between an ultrasound transducer and a target, said method comprising:
providing said transducer with an active area for transmitting and receiving said ultrasound energy,
arranging an ultrasound conducting sheath outwardly of said transducer active area,
providing an ultrasound couplant between said active area and said sheath, said couplant being in vivo biocompatible and comprising polyethylene oxide in a concentration amount of about 0.05 wt. % to about 65 wt. %, and the balance water, said couplant having acoustic properties generally equivalent to acoustic properties of said target,
placing said couplant on said target if said target is located externally on a body,
placing the covered transducer on said target,
transmitting and receiving said ultrasound energy respectively to and/or from said target through said sheath and said ultrasound couplant.

### Claim 31 (depends on 30)

The method of claim 30 wherein said ultrasound couplant further comprises polyalkylene glycol in the amount of 1 to 45 wt. %.

### Claim 32 (depends on 31)

The method of claim 31 wherein said polyalkylene glycol comprises propylene glycol.

### Claim 33

In an ultrasound guided needle puncture procedure wherein an ultrasound transducer is utilized to guide said needle through skin of a patient and into a target within the body of said patient, the improvement comprising:
applying an ultrasound couplant on said skin, said couplant being in vivo biocompatible and comprising polyethylene oxide in a concentration amount of about 0.05 wt. % to about 65 wt., the balance water,
carrying out said needle puncture procedure utilizing said ultrasound transducer to guide said needle to said target,
whereby couplant carried by said needle into said body during the procedure remains in said body where it is biodegradable, bio-inert or bioerodable with respect to said body.

### Claim 34 (depends on 33)

The procedure of claim 33 wherein said ultrasound couplant further comprises polyalkylene glycol in the amount of 1 to 45 wt. %.

### Claim 35 (depends on 34)

The method of claim 34 wherein said polyalkylene glycol comprises propylene glycol.
